Multiparametric Magnetic Resonance Imaging Features Identify Aggressive Prostate Cancer at the Phenotypic and Transcriptomic Level
Alp Tuna Beksaç(Cleveland Clinic), Ashutosh Tewari(Icahn School of Medicine at Mount Sinai), Jennifer Jordan(Canterbury Health Laboratories), Elai Davicioni(Coherus BioSciences (United States)), Mandeep Takhar(Genome British Columbia), Isuru Jayaratna, Sonya Prasad(Massachusetts General Hospital), Sujit S. Nair(George Washington University), Alberto Martini(The University of Texas MD Anderson Cancer Center), Richa Rai(Icahn School of Medicine at Mount Sinai), Ardeshir R. Rastinehad(Royal Free London NHS Foundation Trust), Hari Thulasidass(Icahn School of Medicine at Mount Sinai), Sara Lewis(Icahn School of Medicine at Mount Sinai), Stefanie J. Hectors(Icahn School of Medicine at Mount Sinai), Bachir Taouli(Cornell University), Shivaram Cumarasamy(Icahn School of Medicine at Mount Sinai), Akriti Gupta(Icahn School of Medicine at Mount Sinai), Kamlesh K. Yadav(Icahn School of Medicine at Mount Sinai), Mohamed Alshalalfa(Genome British Columbia), Mark S. Berger(Erasmus MC Cancer Institute), Ugo Giovanni Falagario(Ospedali Riuniti di Foggia), Kenneth Haines(Mount Sinai Hospital), Paige Xu(Icahn School of Medicine at Mount Sinai)
Cited by 30
Related Papers
Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse
|Journal of Clinical Oncology|2001|898
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|798
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|656
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
|Annals of the Rheumatic Diseases|2001|287